About the Authors
- Kavitha Yaddanapudi
-
Contributed equally to this work with: Kavitha Yaddanapudi, Robert A. Mitchell
Affiliation Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
- Robert A. Mitchell
-
Contributed equally to this work with: Kavitha Yaddanapudi, Robert A. Mitchell
Affiliation Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
- Kalyani Putty
-
Affiliation Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
- Sharon Willer
-
Affiliation Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
- Rajesh K. Sharma
-
Affiliation Tumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
- Jun Yan
-
Affiliation Tumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
- Haribabu Bodduluri
-
Affiliation Tumor Immunobiology Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
- John W. Eaton
-
* E-mail: EatonRedox@aol.com
Affiliation Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, United States of America
Competing Interests
The authors have the following interests: The effects reported here are the subject of a pending U.S. Letters patent application on which Drs. Mitchell and Eaton are named as inventors, application number 60/782,672 (U.S. PTO), entitled “Methods and material for immunization against cancer”. It was filed March 15, 2007 (following first submission March 15, 2006). To the best of the authors' knowledge, there has been no office action on it and it remains an application. There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.